{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:45:34Z","timestamp":1790721934679,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Statins possess anti-inflammatory properties and have a protective effect in certain inflammatory conditions; however, their effect on the natural history of pancreatitis is unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim:<\/jats:title>\n            <jats:p>The aim of this study is to assess the effect of statin exposure on the severity of pancreatitis and incidence of organ failure using a propensity-matched approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A historical cohort study was conducted of adult patients with acute pancreatitis (AP) admitted in the Cleveland Clinic Health System between 2007 and 2014. All medication, clinical, and outcomes data were extracted from the electronic medical record. Factors that influence statin use were included in a propensity model to minimize selection bias. Patients on and off statins were matched (1:1) based on the propensity score to simulate a randomized controlled trial. Measured outcomes included pancreatitis severity (Revised Atlanta Classification), incidence of multisystem organ failure (MSOF), new MSOF, acute necrosis, and death. Additional surrogate markers of severity included hospital length of stay, Bedside Index of Severity of Acute Pancreatitis (BISAP), and presence of SIRS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 110 subjects taking a statin at admission were matched with 210 subjects not on a statin. Known baseline factors that may influence statin use and severity of pancreatitis were evenly matched between the 2 groups. Patients on a statin were less likely to develop MSOF, severe AP and necrosis. Although less in-hospital death occurred in the statin group when compared to nonusers, the difference was not statistically significant (2% vs. 4%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.38).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Statin use is associated with decreased severity of AP observed as reduction in both overall MSOF incidence and new MSOF. Prospective randomized controlled trials are needed to determine the efficacy of statin drugs in the treatment of AP.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcg.0000000000000956","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T15:32:23Z","timestamp":1509463943000},"page":"742-746","source":"Crossref","is-referenced-by-count":9,"title":["Association of Statins With Decreased Acute Pancreatitis Severity"],"prefix":"10.1097","volume":"52","author":[{"given":"Peter J.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Digestive Health Institute, University Hospitals Cleveland Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunjam","family":"Modha","sequence":"additional","affiliation":[{"name":"Hospital Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Chua","sequence":"additional","affiliation":[{"name":"Internal Medicine, Medicine Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Chak","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Digestive Health Institute, University Hospitals Cleveland Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Digestive Disease Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Quantitative Health Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Gougol","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios I.","family":"Papachristou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Digestive Disease Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1053\/j.gastro.2015.08.045","article-title":"Burden of gastrointestinal, liver, and pancreatic diseases in the United States","volume":"149","author":"Peery","year":"2015","journal-title":"Gastroenterology"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/gut.48.1.62","article-title":"Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis","volume":"48","author":"Johnson","year":"2001","journal-title":"Gut"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02785915","article-title":"A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis","volume":"21","author":"McKay","year":"1997","journal-title":"Int J Pancreatol"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"16935","DOI":"10.3748\/wjg.v20.i45.16935","article-title":"Immunomodulatory therapies for acute pancreatitis","volume":"20","author":"Li","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MOL.0b013e3283453e41","article-title":"Mechanisms for the anti-inflammatory effects of statins","volume":"22","author":"Bu","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1248\/bpb.28.1394","article-title":"The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, lovastatin (statin) ameliorates CCK-induced acute pancreatitis in rats","volume":"28","author":"Choi","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1476-5381.2009.00612.x","article-title":"Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase\/signal transducers and activators of transcription pathways in human vascular endothelial cells","volume":"159","author":"Jougasaki","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archsurg.2011.897","article-title":"Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis","volume":"147","author":"Chopra","year":"2012","journal-title":"Arch Surg"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12916-015-0368-6","article-title":"Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study","volume":"13","author":"Mansur","year":"2015","journal-title":"BMC Med"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/archinternmed.2009.286","article-title":"Statins for the prevention and treatment of infections: a systematic review and meta-analysis","volume":"169","author":"Tleyjeh","year":"2009","journal-title":"Arch Intern Med"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.CIR.0000138932.17956.F1","article-title":"Prior statin therapy is associated with a decreased rate of severe sepsis","volume":"110","author":"Almog","year":"2004","journal-title":"Circulation"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/bjs.5290","article-title":"Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis","volume":"93","author":"Mofidi","year":"2006","journal-title":"Br J Surg"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.cgh.2009.08.012","article-title":"Early systemic inflammatory response syndrome is associated with severe acute pancreatitis","volume":"7","author":"Singh","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pan.2013.03.008","article-title":"Prior statin therapy is associated with milder course and better outcome in acute pancreatitis\u2014a cohort study","volume":"13","author":"Gornik","year":"2013","journal-title":"Pancreatology"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MPA.0000000000000068","article-title":"Statin use in patients with acute pancreatitis and symptomatic gallstone disease","volume":"43","author":"Pulkkinen","year":"2014","journal-title":"Pancreas"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejim.2015.05.002","article-title":"Prior statin use and the outcomes in patients with first-attack acute pancreatitis: A retrospective cohort study","volume":"26","author":"Shiu","year":"2015","journal-title":"Eur J Intern Med"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/ajg.2013.218","article-title":"American College of Gastroenterology guideline: management of acute pancreatitis","volume":"108","author":"Tenner","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis\u20142012: revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/00003246-199510000-00007","article-title":"Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome","volume":"23","author":"Marshall","year":"1995","journal-title":"Crit Care Med"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/gutjnl-2013-306564","article-title":"Simvastatin is associated with reduced risk of acute pancreatitis: findings from a regional integrated healthcare system","volume":"64","author":"Wu","year":"2015","journal-title":"Gut"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2012.8439","article-title":"Lipid-modifying therapies and risk of pancreatitis: a meta-analysis","volume":"308","author":"Preiss","year":"2012","journal-title":"JAMA"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cyto.2012.04.039","article-title":"TNF-alpha modulates statin effects on secretion and expression of MCP-1, PAI-1 and adiponectin in 3T3-L1 differentiated adipocytes","volume":"60","author":"Lobo","year":"2012","journal-title":"Cytokine"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.fjc.0000175455.46245.c8","article-title":"Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates","volume":"46","author":"Okopien","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/1755-5922.12193","article-title":"Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats postmyocardial infarction","volume":"34","author":"Yang","year":"2016","journal-title":"Cardiovasc Ther"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbrc.2013.01.094","article-title":"Simvastatin inhibits ox-LDL-induced inflammatory adipokines secretion via amelioration of ER stress in 3T3-L1 adipocyte","volume":"432","author":"Wu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jamcollsurg.2016.04.004","article-title":"Perioperative simvastatin therapy in major colorectal surgery: a prospective, double-blind randomized controlled trial","volume":"223","author":"Singh","year":"2016","journal-title":"J Am Coll Surg"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"18285","DOI":"10.1073\/pnas.0907117106","article-title":"Statins inhibit protein lipidation and induce the unfolded protein response in the non-sterol producing nematode Caenorhabditis elegans","volume":"106","author":"Morck","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MOG.0000000000000301","article-title":"New insights into the pathways initiating and driving pancreatitis","volume":"32","author":"Gukovskaya","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nature08762","article-title":"An essential role for XBP-1 in host protection against immune activation in C. elegans","volume":"463","author":"Richardson","year":"2010","journal-title":"Nature"},{"key":"R32-20230913","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2010.11.038","article-title":"Adaptive unfolded protein response attenuates alcohol-induced pancreatic damage","volume":"140","author":"Lugea","year":"2011","journal-title":"Gastroenterology"},{"key":"R33-20230913","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/gut.2007.135665","article-title":"Adiponectin plays a protective role in caerulein-induced acute pancreatitis in mice fed a high-fat diet","volume":"57","author":"Araki","year":"2008","journal-title":"Gut"},{"key":"R34-20230913","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2016.07.897","article-title":"Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms","volume":"253","author":"Chrusciel","year":"2016","journal-title":"Atherosclerosis"},{"key":"R35-20230913","doi-asserted-by":"crossref","first-page":"e2545","DOI":"10.1097\/MD.0000000000002545","article-title":"Atorvastatin use associated with acute pancreatitis: a case-control study in Taiwan","volume":"95","author":"Lai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R36-20230913","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/pds.3858","article-title":"Use of statins and the risk of acute pancreatitis: a population-based case-control study","volume":"24","author":"Kuoppala","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004836-201809000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T21:30:28Z","timestamp":1694640628000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201809000-00014"}},"subtitle":["A Propensity Score Analysis"],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000000956","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}